This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Encephalitis is a rare complication of measles infection and is of three distinct types: (1) acute encephalitis, (2) subacute sclerosing panencephalitis (SSPE), and (3) subacute measles encephalitis (subacute inclusion body encephalopathy, progressive infectious measles encephalitis) in the immunosuppressed. [1] Acute encephalitis during recovery from measles is probably an autoimmune process and not a productive brain tissue infection. SSPE starts its usually progressive course several years after measles infection in early childhood. [1] Brain histology is characterized by inflammatory infiltrates, glial nodules, degeneration of neurons in the gray matter, neuronophagia, hyperplasia of astro- and microglia, and intranuclear inclusion bodies of Cowdry type A with abundant measles virus antigen. [2] Subacute measles encephalitis occurs in patients with defective cellular immunity from lymphoproliferative illnesses or immunosuppressive therapy. Usually several months after a clinical course of measles, encephalitic signs and symptoms such as seizures, myoclonism, stupor, and coma develop. [1] Histologically, diagnostic features include intranuclear eosinophilic and sometimes intracytoplasmic inclusion bodies in neurons and oligodendrocytes with abundant paramyxovirus nucleocapsids and abundant measles virus antigen. [2] Inflammatory cells are often absent because of immunosuppression.
Despite the ubiquity of measles infection and the HIV pandemic, only very few studies on complications of measles virus infection in patients with AIDS have been published. We report here a hemophilic HIV-positive patient who died from subacute measles encephalitis. A short abstract …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Alert Me
Recommended articles
Subacute measles encephalitis in a young man immunosuppressed for ankylosing spondylitis
Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis
Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy